Additional file 1 of Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2
Additional file 1 of Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2
复制标题
BNT162b2 (Pfizer-BioNTech) 和 ChAdOx1 nCoV-19 (Oxford-AstraZeneca) 疫苗降低 SARS-CoV-2 Delta 变体 (B.1.617.2) 感染易感性的有效性的附加文件 1
DOI：
10.6084/m9.figshare.19388922
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Pattni K
中科院分区：
文献类型：
--
作者：
Pattni K
